Astellas Pharma is a Tokyo-based global pharmaceutical company that researches, develops and commercializes prescription medicines. Its marketed portfolio serves patients in oncology, ophthalmology, urology, immunology and women's health, with brands including XTANDI, PADCEV, IZERVAY, VYLOY, VEOZAH/VEOZA and XOSPATA. It was established in April 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.
Its research is organized around primary focuses in blindness and regeneration, genetic regulation, immuno-oncology and induced proximity. For the fiscal year ended March 31, 2026 it reported revenue of JPY 2.14 trillion.
0
open positions at Astellas Pharma
No live listings from Astellas Pharma right now — browse all Tokyo software jobs instead.